Exact Sciences Announces March 26, 2014 for FDA Advisory Committee Meeting
December 03, 2013 at 16:17 PM EST
Exact Sciences Corp. (Nasdaq: EXAS ) today announced that the U.S. Food and Drug Administration's Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee is tentatively scheduled to review